GENSCRIPT BIO(01548): Legend to present latest data at the American Society of Hematology annual meeting.
Kingstron Biotech (01548) announced that Legendary Biotech Co., Ltd. (a joint venture of the company, its shares...)
GENSCRIPT BIO (01548) announced that Legend Biotech Corporation (a company affiliated with the company, whose shares are listed on the Nasdaq Global Select Market in the form of American Depositary Shares) submitted a Form 6-K to the U.S. Securities and Exchange Commission on November 3, 2025 (New York time) (prior to the Hong Kong trading hours on November 4, 2025), and announced that it will present the latest data related to CARVYKTI and other pipelines at the 67th Annual Meeting of the American Society of Hematology, to be held in San Diego from December 6 to 9, 2025.
Related Articles
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
